Delivery Order SPE2DB24D1007-SPE2DB25FCCPD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $4,194.27 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 29, 2025, and represents a child contract issued under a larger indefinite delivery vehicle. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections with a ceiling value of $5,936.87. This delivery order represents a firm fixed price contract with no set-aside designation, executed under competitive procurement procedures. The award is expected to be completed by August 4, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $4,177.46. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,888.45 on July 30, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a firm fixed price transaction with an ultimate completion date of July 31, 2025. The contract does not include a set-aside designation and was competitively awarded. Performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,247.39 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing with a completion date of July 31, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract carries no set-aside designation and...
- The Defense Logistics Agency awarded a $14,216.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injections on July 30, 2025, with completion targeted for July 31, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCPDDelivery Order
The Defense Logistics Agency awarded a $2,697.52 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. The contract carries no set-aside designation, reflecting the open competitive nature of the award. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of medications and medical supplies to support military healthcare programs worldwide. The Zepbound order aligns with the company's established portfolio of federal medical product deliveries spanning diabetes medications, specialty pharmaceuticals, and other critical healthcare commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/23/25 |